Skin Sensitisation Assessment: How Cosmetic Ingredients Are Evaluated Without Animal Testing

Skin sensitisation is one of the most frequently evaluated toxicological endpoints in cosmetic safety assessment, particularly relevant for fragrances, preservatives, and other ingredients with known allergenic potential. It is also one of the clearest examples of how mechanistic toxicology has transformed regulatory safety assessment. Rather than relying on a single animal study, today’s approach integrates multiple non-animal methods that each measure a defined biological event along the skin sensitisation pathway.

Skin sensitisation follows a well-characterised biological sequence known as an Adverse Outcome Pathway (AOP) with four key events. It begins with the molecular initiating event, covalent binding between a sensitising substance and skin proteins. This triggers keratinocyte activation, followed by dendritic cell activation and maturation, and finally T-cell proliferation, the step that produces a clinically observable allergic response. Because these biological events are now individually measurable, the assessment no longer depends on a single animal test to predict sensitisation potential.

OECD Test Guidelines 442C, 442D and 442E collectively address the first three key events of this pathway. OECD TG 442C assesses the molecular initiating event by measuring covalent binding to model skin proteins. OECD TG 442D evaluates keratinocyte activation using cell lines engineered to detect activation of relevant cellular stress pathways. OECD TG 442E covers methods that assess dendritic cell activation using validated human cell-based approaches. Both TG 442C and TG 442D were updated on 2 July 2026, demonstrating that even well-established methods continue to evolve as the underlying science advances.

No single assay is considered sufficient, on its own, to conclude whether a substance is or is not a skin sensitiser. This is where Defined Approaches, described in OECD TG 497, become essential. A Defined Approach combines information from multiple sources, including in chemico, in vitro and, where appropriate, in silico methods, using a fixed data interpretation procedure. The result is a structured, reproducible weight-of-evidence conclusion based on mechanistically relevant evidence rather than any single test outcome.

For formulators and cosmetic safety assessors, the practical implication is straightforward. A skin sensitisation conclusion in a Cosmetic Product Safety Report (CPSR) should be traceable to the key events that were assessed, the OECD methods that were used, and the way the evidence was integrated. As these methods continue to evolve, keeping a safety file’s references current is more than a documentation exercise. It is part of maintaining a scientifically robust and regulatory-defensible safety assessment.

Sources